Cancer

Radiation therapy techniques and combination treatments for sarcoma

By Bench Side Story — 5 days ago

Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.

As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.

Post Views: 3,771

Biological interactions of extracellular vesicles

By Bench Side Story — 2 months ago

Raluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology.

Post Views: 198

Dietary Interventions Influencing Neurological Outcomes

By Bench Side Story — 3 months ago

With over a decade of experience as a dietitian and nutritionist, Carolina Blagojevic Castro specialises in providing personalised dietary guidance and customised meal planning tailored to meet each client’s unique health needs. She is known for her engaging and educational presentations on topics related to health and nutrition, sharing practical, evidence-based insights with both community groups and professional audiences.

Post Views: 541

Good and bad extracellular vesicles in health and disease

By Bench Side Story — 3 months ago

Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.

Post Views: 2,104

Role of metabolic dysfunction in advanced prostate cancer

By Bench Side Story — 7 months ago

Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.

Post Views: 417

Next generation nanomedicine and radiopharmaceuticals to treat cancer

By Bench Side Story — 10 months ago

Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.

Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.

Post Views: 719

Engineering bacteria to detect colorectal cancer cells

By Bench Side Story — 1 year ago

An international team of researchers from Adelaide and the United States has engineered bacteria capable of detecting mutated DNA released from colorectal cancer cells, opening the door to faster disease detection.